MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/ene.70383

Медицинская библиотека · European journal of neurology · 2025

Preliminary Validation of the FCD-Q8 Tool in Functional Cognitive Disorder and Early Alzheimer's Disease: A Biomarker-Verified Case-Control Study.

García-Roldán Ernesto, Almodóvar-Sierra Ángela, Luque-Tirado Andrea, Marín Cabañas Alba Marta, Bernal Sánchez-Arjona María, Franco-Macías Emilio

СтатьяВалидационное исследованиеПеревод в очереди

Аннотация

BACKGROUND

Differentiating functional cognitive disorder (FCD) from early Alzheimer's disease (eAD) through clinical interview alone is challenging and may lead to unnecessary testing. We aimed to assess the diagnostic accuracy of the Functional Cognitive Disorder Questionnaire-8 (FCD-Q8) and examine its psychometric properties.

METHODS

In this cross-sectional, phase 1 case-control study at a tertiary memory clinic in Seville, Spain, 78 adults with memory complaints were recruited: 44 with biomarker-verified eAD (positive CSF or amyloid PET; GDS 3-4) and 34 with FCD (negative biomarkers and clinical internal inconsistency). A blinded neuropsychologist administered the FCD-Q8. The primary outcome was diagnostic accuracy (area under the ROC curve [AUC], sensitivity, and specificity). Secondary outcomes included internal consistency (Cronbach's α with 95% CI) and item characteristics using two-parameter logistic Item Response Theory (2PL IRT).

RESULTS

Participants had a mean age of 67.5 years (SD ± 7.1); 59% were female. The FCD-Q8 demonstrated good diagnostic accuracy with an AUC of 0.87 (95% CI 0.78-0.95). At a cut-off ≥ 5, sensitivity was 76.5% and specificity 88.6%. Internal consistency was moderate (α = 0.61; 95% CI 0.47-0.70). 2PL IRT analysis showed that items related to checking behaviours were the most discriminative (difficulty 3.70), while questions on compound statements and premorbid self-appraisal were the least discriminative. Attending the clinical interview alone was the most difficult item (1.47).

CONCLUSION

The FCD-Q8 demonstrated good diagnostic utility to distinguish FCD from eAD in biomarker-verified populations. These findings support progression to a subsequent prospective validation phase, which could further establish its clinical and research applicability.

Для цитирования: García-Roldán Ernesto, Almodóvar-Sierra Ángela, Luque-Tirado Andrea, Marín Cabañas Alba Marta, Bernal Sánchez-Arjona María, Franco-Macías Emilio. Preliminary Validation of the FCD-Q8 Tool in Functional Cognitive Disorder and Early Alzheimer's Disease: A Biomarker-Verified Case-Control Study.. European journal of neurology. 2025. DOI: 10.1111/ene.70383.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.